Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Accenture
Deloitte
Colorcon
Harvard Business School
Medtronic
Baxter
Argus Health
McKinsey

Generated: May 26, 2018

DrugPatentWatch Database Preview

Florbetaben f-18 - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for florbetaben f-18 and what is the scope of florbetaben f-18 freedom to operate?

Florbetaben f-18
is the generic ingredient in one branded drug marketed by Piramal Imaging and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Florbetaben f-18 has thirty-three patent family members in twenty-five countries.

One supplier is listed for this compound.
Summary for florbetaben f-18
International Patents:33
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 1
Clinical Trials: 10
Patent Applications: 8
DailyMed Link:florbetaben f-18 at DailyMed
Pharmacology for florbetaben f-18
Synonyms for florbetaben f-18
[18F]BAY 94-9172
18F-BAY94-9172
18F-Florbetaben
4-((1E)-2-(4-(2-(2-(2-((sup 18(f))fluoroethoxy)ethoxy)ethoxy)phenyl)eth-1-en-1-yl)-N-methylaniline
4-[(E)-2-[4-[2-[2-(2-fluoranylethoxy)ethoxy]ethoxy]phenyl]ethenyl]-N-methylaniline
4-{(E)-2-[4-(2-{2-[2-((18)F)fluoroethoxy]ethoxy}ethoxy)phenyl]ethenyl}-N-methylaniline
902143-01-5
AV-1
BAY 94-9172
BAY-949172
BAY94-9172
CHEBI:79033
CHEMBL566752
DB09148
DTXSID20238065
Florbetaben
florbetaben ((18)F)
Florbetaben ((sup 18)F)
Florbetaben (18F)
Florbetaben (18F) (JAN/INN)
Florbetaben (18F) [INN]
Florbetaben 18F [INN]
Florbetaben F 18
Florbetaben F18
Florbetaben f18 [USAN]
GTPL7769
Neuraceq
Neuraceq (TN)
SCHEMBL11301755
TLA7312TOI
UNII-TLA7312TOI

US Patents and Regulatory Information for florbetaben f-18

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Piramal Imaging NEURACEQ florbetaben f-18 SOLUTION;INTRAVENOUS 204677-001 Mar 19, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Piramal Imaging NEURACEQ florbetaben f-18 SOLUTION;INTRAVENOUS 204677-001 Mar 19, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Non-Orange Book US Patents for florbetaben f-18

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,858,072 Stilbene derivatives and their use for binding and imaging amyloid plaques ➤ Sign Up
8,465,726 Stilbene derivatives and their use for binding and imaging amyloid plaques ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Supplementary Protection Certificates for florbetaben f-18

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2015005 Lithuania ➤ Sign Up PRODUCT NAME: FLORBETABENUM (18F); REGISTRATION NO/DATE: EU/1/13/906/001 20140220
2015 Austria ➤ Sign Up PRODUCT NAME: FLORBETABEN (18 F); REGISTRATION NO/DATE: EU/1/13/906/001 (MITTEILUNG) 20140224
647 Luxembourg ➤ Sign Up PRODUCT NAME: FLORBETABEN (18F). FIRST REGISTRATION: 20140224
2015005,C2213652 Lithuania ➤ Sign Up PRODUCT NAME: FLORBETABENAS (18F); REGISTRATION NO/DATE: EU/1/13/906/001 20140220
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Teva
UBS
Healthtrust
Accenture
Federal Trade Commission
Harvard Business School
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.